LYME DISEASE BIOBANK Trademark

Trademark Overview

On Monday, July 10, 2017, a trademark application was filed for LYME DISEASE BIOBANK with the United States Patent and Trademark Office. The USPTO has given the LYME DISEASE BIOBANK trademark a serial number of 87522315. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 27, 2024. This trademark is owned by Lyme Disease Biobank Foundation. The LYME DISEASE BIOBANK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research; Medical research
lyme disease biobank

General Information

Serial Number87522315
Word MarkLYME DISEASE BIOBANK
Filing DateMonday, July 10, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 27, 2024
Registration Number5494160
Registration DateTuesday, June 12, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkLYME DISEASE BIO BANK
NOT AVAILABLE"BIOBANK"
Goods and ServicesBiotechnology research; Medical research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 27, 2024
Primary Code042
First Use Anywhere DateFriday, May 1, 2015
First Use In Commerce DateFriday, May 1, 2015

Trademark Owner History

Party NameLyme Disease Biobank Foundation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPortland, OR 97221
Party NameLyme Disease Biobank Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortland, OR 97221

Trademark Events

Event DateEvent Description
Sunday, July 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 5, 2017ASSIGNED TO EXAMINER
Thursday, July 13, 2017NEW APPLICATION ENTERED
Thursday, October 12, 2017NON-FINAL ACTION WRITTEN
Wednesday, March 28, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 16, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, April 16, 2018EXAMINERS AMENDMENT E-MAILED
Monday, April 16, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 12, 2017NON-FINAL ACTION E-MAILED
Thursday, October 12, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 7, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 7, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 16, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, April 26, 2018ASSIGNED TO LIE
Tuesday, June 12, 2018REGISTERED-SUPPLEMENTAL REGISTER
Monday, June 12, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 27, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, May 8, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 16, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, May 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

biobank disease lyme research medical biotechnology